Application of mucosecretolytics of plant origin in otorinolaryngology

In modern otorhinolaryngology the use of herbal remedies, so-called clinical homeopathy, is widely used both as a basic and as part of complex therapy. A special place among this category belongs to medicines with secretolytic and mucolytic properties. This is due to the developed mucociliary system of the mucous membranes of the upper respiratory tract, which primarily suffers in acute and chronic inflammatory diseases. Most chemical mucoactive preparations have only one of the three mucosecretolytic effects and have a large number of contraindications. Herbal preparations, such as those containing Myrtol standardized, have secretolytic and mucolytic properties at the same time. Phytopreparations have deservedly occupied a leading place in the treatment of otorhinolaryngological diseases, as they have practically no contraindications and are successfully used in patients with comorbid pathology, children of all age groups and pregnant women. The efficacy of using preparations containing Myrtol standardized in the treatment of acute and chronic inflammatory diseases of the ENT organs and chronic atrophic diseases of the upper respiratory tract has been studied in a number of randomized clinical trials. The authors analysed 21 literature sources, reflecting the results of using mucosecretolytic drugs in otorhinolaryngology. In the complex treatment of acute rhinosinusitis and rhinopharyngitis the use of natural mucosecretolytic drugs significantly reduces the period of disability and avoids bacterial complications in both adult and paediatric practice. Mucolytic and antioxidant properties of preparations containing Myrtol allow for long-term effective therapy of subatrophic and atrophic processes of pharyngeal and laryngeal mucosa in elderly patients with comorbid pathology. An analysis of randomised trials has proven the efficacy of plant-based mucosecretolytics in the treatment of not only acute but also chronic upper respiratory tract diseases

1. Gromakov VA. Mirtol Standardized in Treatment of Acute Rhinosinusitis. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2012;(1):57–58. (In Russ.) Available at: https://mediasphera.ru/issues/vestnik-otorinolaringologii/2012/1/downloads/ru/030042-46682012117.

2. Orlova N.V. Complex Therapy of Acute Respiratory Diseases. Meditsinskiy sovet = Medical Council. 2019;(15):91–97. (In Russ.) doi: 10.21518/2079-701X-2019-15-91-97.

3. Shaller M. Gelomyrtol® Forte. Retsept = The Recipe. 2008;(1):107–108. (In Russ.) Available at: https://elibrary.ru/item.asp?id=19549334.

4. Korotkova T.V., Demchenko E.V. New Approach to Hypertrophic Pharyngitis Treatment. Golos i rech’ = Voice and Speech. 2013;(2):11–17. (In Russ.) Available at: http://www.golosrech.ru/download/golos_i_rech2013-2.pdf.

5. Deliagin V.М. The Herbal Preparations in the Treatment of Cough in Children with Respiratory Infections. Meditsinskiy sovet = Medical Council. 2019;(2):82–86. (In Russ.) doi: 10.21518/2079-701X-2019-2-82-86.

6. Prall S., Bowles E.J., Bennett K., Cooke C.G., Agnew T., Steel A., Hausser T. Effects of Essential Oils on Symptoms and Course (Duration and Severity) of Viral Respiratory Infections in Humans: A Rapid Review. Adv Integr Med. 2020;7(4):218–221. doi: 10.1016/j.aimed.2020.07.005.

7. Karpova E.P., Tulupov D.A., Emel’yanova M.P. Use of Myrtol Standardized in the Treatment of Children with Acute Rhinosinusitis. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2016;(1):47–50. (In Russ.) doi: 10.17116/otorino201681147-50.

8. Paparoupa M., Gillissen A. Is Myrtol® Standardized a New Alternative toward Antibiotics? Pharmacogn Rev. 2016;10(20):143–146. doi: 10.4103/0973-7847.194045.

9. Li Y.Y., Liu J., Li C.W., Subramaniam S., Chao S.S., Yu F.G. et al. Myrtol Standardized Affects Mucociliary Clearance. Int Forum Allergy Rhinol. 2017;7(3):304–311. doi: 10.1002/alr.21878.

10. Ryazantsev S.V., Konoplev O.I., Sapova K.I. Mycolytic Therapy of Sinusitis. Vestnik otorinolaringologii = Bulletin of Otorhinolaryngology. 2014;(6):61–63. (In Russ.) doi: 10.17116/otorino2014661-63.

11. Koch A.K., Klose P., Lauche R., Cramer H., Baasch J., Dobos G.J., Langhorst J. A Systematic Review of Phytotherapy for Acute Rhinosinusitis. Forsch Komplementmed. 2016;23(3):165–169. doi: 10.1159/000447467.

12. Dykewicz M.S., Hamilos D.L. Rhinitis and Sinusitis. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S103-S115. doi: 10.1016/j.jaci.2009.12.989.

13. Guo R., Canter P.H., Ernst E. Herbal Medicines for the Treatment of Rhinosinusitis: A Systematic Review. Otolaryngol Head Neck Surg. 2006;135(4):496–506. doi: 10.1016/j.otohns.2006.06.1254.

14. Evdokimova O.V. Sinusitis and homeopathic medicines. Meditsinskiy alfavit = Medical Alphabet. 2016;(32-2):20–23. (In Russ.) Available at: https://queisser.ru/specialists/med_abs_32_2016.pdf.

15. Cwientzek U., Ottillinger B., Arenberger P. Acute Bronchitis Therapy with Ivy Leaves Extracts in a Two-Arm Study. A Double-Blind, Randomised Study vs. an Other Ivy Leaves Extract. Phytomedicine. 2011;18(13):1105– 1109. doi: 10.1016/j.phymed.2011.06.014.

16. Han D., Wang N., Zhang L. The Effect of Myrtol Standardized on Human Nasal Ciliary Beat Frequency and Mucociliary Transport Time. Am J Rhinol Allergy. 2009;23(6):610–614. doi: 10.2500/ajra.2009.23.3401.

17. Zeil S., Schwanebeck U., Vogelberg C. Tolerance and Effect of an Add-On Treatment with a Cough Medicine Containing Ivy Leaves Dry Extract on Lung Function in Children with Bronchial Asthma. Phytomedicine. 2014;21(10):1216–1220. doi: 10.1016/j.phymed.2014.05.006.

18. Kryukov A.I., Studenyy M.Ye., Artemyev M.Ye., Chumakov P.L., Rynkov D.A., Gorin D.S. Treatment of Patients with Rhinosinusitis: The Possibilities of Conservative and Surgical Intervention. Meditsinskiy sovet = Medical Council. 2012;(11):92–96. (In Russ.) Available at: https://cyberleninka.ru/article/n/lechenie-patsientov-s-rinosinusitami-vozmozhnosti-konservativnogo-i-operativnogo-vozdeystviya.

19. Zhao Y.L., Miao F.F., Yang J.H. Individualized Treatment of Chronic Pharyngitis and Its Clinical Significance. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32(13):1006–1008. doi: 10.13201/j.issn.1001-1781.2018.13.011.

20. Li Z., Huang J., Hu Z. Screening and Diagnosis of Chronic Pharyngitis Based on Deep Learning. Int J Environ Res Public Health. 2019;16(10):1688. doi: 10.3390/ijerph16101688.

21. Rantzsch U., Vacca G., Dück R., Gillissen A. Anti-Inflammatory Effects of Myrtol Standardized and Other Essential Oils on Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease. Eur J Med Res. 2009;14(4 Suppl.):205–209. doi: 10.1186/2047-783x-14-s4-205.